Valuation: Hofseth BioCare ASA

Market Cap 697M 74.11M 63.94M 59.94M 54.67M 102M 7.08B 104M 703M 276M 3.54B 278M 272M 11.78B P/E 2024
-5.58x
P/E 2025 -4x
Enterprise Value 990M 105M 90.81M 85.12M 77.63M 145M 10.06B 148M 998M 391M 5.03B 395M 387M 16.73B EV / Sales 2024
3.18x
EV / Sales 2025 3.26x
Free-Float
76.37%
Yield 2024 *
-
Yield 2025 -
1 day+0.38%
1 week-1.11%
Current month-1.11%
1 month+3.89%
3 months+1.52%
6 months-2.91%
Current year+1.14%
1 week 1.28
Extreme 1.28
1.35
1 month 1.22
Extreme 1.22
1.59
Current year 1.1
Extreme 1.1
2.01
1 year 1.1
Extreme 1.1
2.42
3 years 1.1
Extreme 1.1
3.6
5 years 1.1
Extreme 1.1
7.88
10 years 1.1
Extreme 1.1
10.95
Manager TitleAgeSince
Chief Executive Officer 53 2022-07-31
Chief Tech/Sci/R&D Officer - -
Chief Tech/Sci/R&D Officer 65 2009-12-31
Director TitleAgeSince
Director/Board Member 55 2015-04-30
Director/Board Member - -
Director/Board Member - 2021-12-02
Date Insider Type Main position Quantity % Market Cap.
7/14/23 Buy 74,000 0.0187%
2/28/23 Buy

Chief Technology Officer

200,000 0.0506%
2/17/23 Buy

Director

100,000 0.0253%
Change 5-day change 1-year change 3-year change Capi.($)
+0.38%-1.11%-23.50%-55.50% 73.58M
-2.84%-3.08%+8.81%-24.48% 257B
-2.25%-0.69%+0.16%-13.59% 81.19B
-2.97%-4.37%-9.46%+21.42% 50.08B
0.00%+0.06%+129.44%+503.62% 46.09B
+1.04%+6.14%+36.05%-1.07% 38.77B
-1.72%-0.71%+1.72%-17.51% 37.01B
+2.78%+10.10%+43.06%+96.13% 33.39B
-2.01%-4.55%+34.94%+33.92% 30.25B
-2.98%-2.25%-10.55%-26.25% 30.25B
Average -1.06%+0.98%+21.07%+51.67% 60.39B
Weighted average by Cap. -1.89%+0.68%+18.88%+32.54%

Financials

2024 2025
Net sales 266M 28.23M 24.35M 22.83M 20.82M 38.85M 2.7B 39.68M 268M 105M 1.35B 106M 104M 4.49B 256M 27.25M 23.51M 22.04M 20.1M 37.5M 2.6B 38.31M 258M 101M 1.3B 102M 100M 4.33B
Net income -125M -13.32M -11.49M -10.77M -9.82M -18.33M -1.27B -18.73M -126M -49.55M -637M -50M -48.92M -2.12B -135M -14.34M -12.37M -11.6M -10.58M -19.73M -1.37B -20.16M -136M -53.33M -685M -53.83M -52.66M -2.28B
Net Debt 145M 15.45M 13.33M 12.49M 11.39M 21.26M 1.48B 21.72M 146M 57.46M 738M 57.99M 56.73M 2.46B 293M 31.13M 26.86M 25.18M 22.96M 42.85M 2.98B 43.77M 295M 116M 1.49B 117M 114M 4.95B
Logo Hofseth BioCare ASA
Hofseth Biocare ASA is a Norway-based biotech company that offers ingredients and finished products for humans and animals. The Company’s business is development, manufacturing, marketing and sale of marine ingredients such as oil, calcium and protein products. Its main products are Salmon protein hydrolysate (ProGo), which is a protein for sports, endurance, and recovery powders; Fresh, all-natural salmon oil (OmeGo) that has a full spectrum of omega fatty acids, including EPA, DHA and DPA, totaling 21 different fatty acids; Calcium bone powder (CalGo) is a natural marine collagenic bone powder and CollaGo is a Collagen Peptide powder optimised to improve the beauty of hair, skin and nails. Hofseth BioCare's headquarters are in Aalesund with branches in Oslo, Chicago, Mumbai, Tokyo and Menlo Park, California.
Employees
81
Date Price Change Volume
26-08-17 NOK 1.335 +0.38% 3,165
26-08-14 NOK 1.330 +0.76% 42,916
26-08-13 NOK 1.320 +1.93% 120,669
26-08-12 NOK 1.295 -1.89% 100,120
26-08-11 NOK 1.320 -1.12% 8,961